Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | FNTA | P49354 | 1/20 | 0.56 |
| ▸ | FNTB | P49356 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.52 |
| ▸ | SQLE | Q14534 | 6/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30990927 | 1.00 | KMT2A (0.58) | KMT2AFNTAFNTBMEN1CYP3A4 | |
| SCHEMBL11670568 | 0.98 | KMT2A (0.61) | KMT2AFNTAFNTBMEN1CYP3A4 | |
| SCHEMBL11620625 | 0.98 | KMT2A (0.61) | KMT2AFNTAFNTBMEN1CYP3A4 | |
| SCHEMBL11529352 | 0.98 | KMT2A (0.61) | KMT2AFNTAFNTBMEN1CYP3A4 | |
| SCHEMBL10742587 | 0.84 | KMT2A (0.48) | KMT2AFNTAFNTBMEN1CYP3A4 | |
| SCHEMBL18529415 | 0.84 | KMT2A (0.48) | KMT2AFNTAFNTBMEN1CYP3A4 | |
| SCHEMBL18528951 | 0.84 | KMT2A (0.48) | KMT2AFNTAFNTBMEN1CYP3A4 | |
| SCHEMBL536905 | 0.83 | KMT2A (0.58) | KMT2AFNTAFNTBMEN1CYP3A4 | |
| SCHEMBL28446487 | 0.83 | KMT2A (0.58) | KMT2AFNTAFNTBMEN1CYP3A4 | |
| SCHEMBL6421530 | 0.82 | KMT2A (0.56) | KMT2AFNTAFNTBMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3817 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12622861-B2 | Stable wash composition | CONOPCO, INC. (US) | 2026-05-12 | — | — | US | claimed |
| US-20260125432-A1 | MALTOSE DEPENDENT DEGRONS, MALTOSE-RESPONSIVE PROMOTERS, STABILIZATION CONSTRUCTS, AND THEIR USE IN PRODUCTION OF NON-CATABOLIC COMPOUNDS | AMYRIS INC (US) | 2026-05-07 | — | — | US | claimed |
| WO-2026087246-A1 | BIOTECHNOLOGICAL PRODUCTION OF PHYTOL | BASF SE (DE) | 2026-04-30 | — | — | WO | claimed |
| EP-4713469-A1 | METHOD OF REDUCING EMULSION FORMATIONDURING FERMENTATION PROCESS | DSM IP Assets B.V. (NL) | 2026-03-25 | — | — | EP | claimed |
| EP-4171489-B1 | SANITIZING COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2026-03-25 | — | — | EP | claimed |
| US-20260071239-A1 | COMPOSITIONS AND METHODS FOR IMPROVED CELL CULTURE EFFICIENCY | AMYRIS INC (US) | 2026-03-12 | — | — | US | claimed |
| EP-4705495-A2 | METHODS FOR IMPROVED CELL CULTURE PERFORMANCE AND PRODUCT RECOVERY | Amyris, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-12569433-B2 | Microemulsion delivery systems for water-based beverages | Quicksilver Scientific, Inc. (US) | 2026-03-10 | — | — | US | claimed |
| US-12478566-B2 | Color stable skin benefit compositions | CONOPCO, INC. (US) | 2025-11-25 | — | — | US | claimed |
| EP-4626988-A1 | BIO BASED NATURAL RUBBER SOLUTIONS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-10-08 | — | — | EP | claimed |
| WO-1998000091-A2 | ANTIFUNGAL AGENTS | MILLENNIUM PHARMACEUTICALS, INC. (US) | 1998-01-08 | — | — | WO | claimed |
| US-5663461-A | HYDROLYSIS OF ESTER | KURARAY CO., LTD. (JP) | 1997-09-02 | — | — | US | claimed |
| WO-1997019091-A1 | NOVEL GERANYLGERANYL-DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND RELATED PHARMACEUTICAL COMPOSITIONS | LABORATORI BALDACCI S.P.A. (IT) | 1997-05-29 | — | — | WO | claimed |
| US-5602184-A | ADMINISTERING TERPENE IN THE FORM OF FARNESOL, PHYTOL AND GERANYLGERANIOL TO THE MAMMAL SUFFERING FROM PROSTRATE CANCER | THE UNITED STATES OF AMERICA AS REPRESENTED BY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-02-11 | — | — | US | claimed |
| WO-1996041527-A1 | TERPENES FOR REDUCING THE EFFECT OF PHEROMONE ON LEPIDOPTERA | BASF AKTIENGESELLSCHAFT (DE) | 1996-12-27 | — | — | WO | claimed |
| WO-1994020080-A9 | USE OF MONOTERPENES, SESQUITERPERNES AND DITERPERNES FOR THE TREATMENT OF CANCER | — | 1994-10-27 | — | — | WO | claimed |
| WO-1994020080-A1 | USE OF MONOTERPENES, SESQUITERPERNES AND DITERPERNES FOR THE TREATMENT OF CANCER | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, ASREPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-09-15 | — | — | WO | claimed |
| US-4062879-A | Process for synthesis of coenzyme Q compounds | EISAI CO., LTD. (JA) | 1977-12-13 | — | — | US | claimed |
| US-4061660-A | Process for synthesis of coenzyme Q compounds | EISAI CO., LTD. (JA) | 1977-12-06 | — | — | US | claimed |
| US-4039573-A | ACID CATALYST | EISAI CO., LTD. (JA) | 1977-08-02 | — | — | US | claimed |